BlackRock Enhanced Capital and Income Fund, Inc. (CII) Reaches $15.86 Formed H&S; Last Week Silence Therapeutics plc (LON:SLN) Analysts

Silence Therapeutics plc (LON:SLN) Logo

Among 2 analysts covering Silence Therapeutics PLC (LON:SLN), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Silence Therapeutics PLC had 12 analyst reports since September 29, 2015 according to SRatingsIntel. Peel Hunt maintained the shares of SLN in report on Tuesday, April 3 with “Buy” rating. The firm has “Buy” rating by Peel Hunt given on Monday, January 8. On Thursday, December 28 the stock rating was maintained by Peel Hunt with “Buy”. Peel Hunt maintained it with “Buy” rating and GBX 275 target in Monday, January 22 report. The firm has “Buy” rating given on Tuesday, December 20 by Canaccord Genuity. The stock of Silence Therapeutics plc (LON:SLN) has “Buy” rating given on Thursday, February 1 by Peel Hunt. Canaccord Genuity maintained it with “Buy” rating and GBX 249 target in Monday, January 9 report. The stock has “Buy” rating by Canaccord Genuity on Tuesday, September 27. The stock of Silence Therapeutics plc (LON:SLN) has “Buy” rating given on Tuesday, September 29 by Canaccord Genuity. The stock of Silence Therapeutics plc (LON:SLN) earned “Buy” rating by Canaccord Genuity on Thursday, August 11. See Silence Therapeutics plc (LON:SLN) latest ratings:

03/04/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 277.00 Maintain
26/03/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 277.00 New Target: GBX 277.00 Maintain
01/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 275.00 New Target: GBX 275.00 Maintain
22/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 275.00 New Target: GBX 275.00 Maintain
08/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 276.00 New Target: GBX 276.00 Maintain
28/12/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 275.00 New Target: GBX 275.00 Maintain
14/12/2017 Broker: Peel Hunt Rating: Buy New Target: GBX 276.00 Initiates Starts

BlackRock Enhanced Capital and Income Fund, Inc. (CII) formed H&S with $14.43 target or 9.00% below today’s $15.86 share price. BlackRock Enhanced Capital and Income Fund, Inc. (CII) has $699.77 million valuation. It closed at $15.86 lastly. It is down 9.11% since April 24, 2017 and is uptrending. It has underperformed by 2.44% the S&P500.

The stock decreased 1.03% or GBX 1.75 during the last trading session, reaching GBX 168.25. About 15,000 shares traded. Silence Therapeutics plc (LON:SLN) has 0.00% since April 24, 2017 and is . It has underperformed by 11.55% the S&P500.

Silence Therapeutics plc focuses on the discovery, development, and delivery of RNA therapeutics. The company has market cap of 117.81 million GBP. The firm creates short interfering RNA molecules that trigger the RNAi pathway and mediate the degradation of specific target messenger RNAs. It currently has negative earnings. It is developing Atu027, a drug candidate that is in Phase IIa study for use in the treatment of pancreatic cancer, as well as various GalNAc-siRNA candidates for use in the treatment of iron overload disorders, acromegaly, cardiovascular disease, alcohol use disorder, and other metabolic diseases.

Investors sentiment decreased to 0.83 in Q4 2017. Its down 0.09, from 0.92 in 2017Q3. It dropped, as 7 investors sold BlackRock Enhanced Capital and Income Fund, Inc. shares while 16 reduced holdings. 5 funds opened positions while 14 raised stakes. 7.34 million shares or 1.03% less from 7.42 million shares in 2017Q3 were reported. Brinker Inc has 0.03% invested in BlackRock Enhanced Capital and Income Fund, Inc. (NYSE:CII) for 49,158 shares. Financial Architects owns 4,945 shares. Regions Fincl invested in 0% or 3,968 shares. Financial Bank Of Nova Scotia reported 0.01% of its portfolio in BlackRock Enhanced Capital and Income Fund, Inc. (NYSE:CII). Baldwin Brothers Inc Ma holds 0% or 1,000 shares. Of Vermont holds 750 shares or 0% of its portfolio. Shaker Financial Svcs Ltd Limited Liability Company owns 0.46% invested in BlackRock Enhanced Capital and Income Fund, Inc. (NYSE:CII) for 59,932 shares. Signature Advsr Lc reported 269,207 shares. Barrett Asset Mngmt stated it has 775 shares or 0% of all its holdings. Lpl Ltd Liability Co stated it has 0% of its portfolio in BlackRock Enhanced Capital and Income Fund, Inc. (NYSE:CII). Wells Fargo & Mn reported 327,121 shares. Bb&T Securities Ltd Llc reported 27,511 shares. 1607 Cap Prtnrs Llc reported 559,500 shares or 0.51% of all its holdings. Invesco invested in 0.01% or 934,964 shares. Whittier Trust Co Of Nevada Inc has invested 0.05% in BlackRock Enhanced Capital and Income Fund, Inc. (NYSE:CII).